SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17075126
Source:
http://linkedlifedata.com/resource/pubmed/id/17075126
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008902
,
umls-concept:C0017337
,
umls-concept:C0027819
,
umls-concept:C0030705
,
umls-concept:C0035647
,
umls-concept:C0205210
,
umls-concept:C0521116
,
umls-concept:C0600597
,
umls-concept:C1514983
,
umls-concept:C1880202
pubmed:issue
31
pubmed:dateCreated
2006-10-31
pubmed:abstractText
To develop a gene expression-based classifier for neuroblastoma patients that reliably predicts courses of the disease.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1527-7755
pubmed:author
pubmed-author:BertholdFrankF
,
pubmed-author:BrorsBenediktB
,
pubmed-author:EilsRolandR
,
pubmed-author:ErnestusKarenK
,
pubmed-author:FischerMatthiasM
,
pubmed-author:HaasStefanS
,
pubmed-author:HeroBarbaraB
,
pubmed-author:KönigRainerR
,
pubmed-author:KahlertYvonneY
,
pubmed-author:OberthuerAndréA
,
pubmed-author:SchwabManfredM
,
pubmed-author:SpitzRüdigerR
,
pubmed-author:WarnatPatrickP
,
pubmed-author:WestermannFrankF
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5070-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:17075126-Disease-Free Survival
,
pubmed-meshheading:17075126-Gene Expression Profiling
,
pubmed-meshheading:17075126-Gene Expression Regulation, Neoplastic
,
pubmed-meshheading:17075126-Germany
,
pubmed-meshheading:17075126-Humans
,
pubmed-meshheading:17075126-Japan
,
pubmed-meshheading:17075126-Multivariate Analysis
,
pubmed-meshheading:17075126-Neuroblastoma
,
pubmed-meshheading:17075126-Odds Ratio
,
pubmed-meshheading:17075126-Oligonucleotide Array Sequence Analysis
,
pubmed-meshheading:17075126-Predictive Value of Tests
,
pubmed-meshheading:17075126-Proportional Hazards Models
,
pubmed-meshheading:17075126-Reproducibility of Results
,
pubmed-meshheading:17075126-Risk Assessment
,
pubmed-meshheading:17075126-Survival Analysis
,
pubmed-meshheading:17075126-Tumor Markers, Biological
,
pubmed-meshheading:17075126-United States
pubmed:year
2006
pubmed:articleTitle
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
pubmed:affiliation
Children's Hospital, Department of Pediatric Oncology and Hematology, University of Cologne, Kerpener Strasse 62, D-50924 Cologne, Germany. andre.oberthuer@uk-koeln.de
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't